Investing.com - Financial Markets Worldwide

MediciNova Inc (MNOV)

NASDAQ
Symbol
Exchange
Currency
MNOV·NASDAQ·USD
4875·Tokyo·JPY
Currency in USD
1.300
-0.040(-2.99%)
Closed·
After Hours
1.3000.000(0.00%)
·
MNOV Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected today
MNOV is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
1.2891.340
52 wk Range
1.1212.550
Key Statistics
Edit
Prev. Close
1.339
Open
1.32
Day's Range
1.289-1.34
52 wk Range
1.121-2.55
Volume
47.18K
Average Volume (3m)
26.6K
1-Year Change
15.43%
Book Value / Share
1.02
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MNOV Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
7.000
Upside
+438.46%
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 8
Quickly burning through cash
Unlock InvestingPro

MediciNova Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

MediciNova Inc Company Profile

MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company develops MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent in Phase 2b/3 clinical trial for treating neurological and other disorders, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction, as well as prevention of acute respiratory distress syndrome, and long COVID. It is also developing MN-001 (tipelukast), an orally bioavailable small molecule compound in Phase 2 clinical trial to treat fibrotic and other metabolic disorders, including nonalcoholic fatty liver disease and hypertriglycedemia. The company has a license agreement with Kyorin Pharmaceuticals for the development and commercialization of MN-166 and MN-001. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California.

Industry
Biotechnology & Medical Research
Sector
Healthcare
Employees
13
Market
United States

Compare MNOV to Peers and Sector

Metrics to compare
MNOV
Peers
Sector
Relationship
P/E Ratio
−5.7x−3.0x−0.5x
PEG Ratio
0.190.010.00
Price/Book
1.3x2.5x2.6x
Price / LTM Sales
-54.7x3.3x
Upside (Analyst Target)
-183.0%42.9%
Fair Value Upside
Unlock5.1%6.2%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 7.000
(+438.46% Upside)

Earnings

Latest Release
May 13, 2025
EPS / Forecast
-0.06 / --
Revenue / Forecast
-- / --
EPS Revisions
a
a
Unlock
Last 90 days

MNOV Income Statement

People Also Watch

AeroVironment
250.49
AVAV
+2.48%
Sarepta
18.80
SRPT
+4.79%
Vor Biopharma
1.660
VOR
-16.58%
INmune Bio
2.42
INMB
+0.83%
Soligenix Inc
2.5600
SNGX
+4.92%

FAQ

What Stock Exchange Does MediciNova Trade On?

MediciNova is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for MediciNova?

The stock symbol for MediciNova is "MNOV."

What Is the MediciNova Market Cap?

As of today, MediciNova market cap is 64.20M.

What Is MediciNova's Earnings Per Share (TTM)?

The MediciNova EPS (TTM) is -0.23.

When Is the Next MediciNova Earnings Date?

MediciNova will release its next earnings report on 11 Aug 2025.

From a Technical Analysis Perspective, Is MNOV a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has MediciNova Stock Split?

MediciNova has split 0 times.

How Many Employees Does MediciNova Have?

MediciNova has 13 employees.

What is the current trading status of MediciNova (MNOV)?

As of 12 Aug 2025, MediciNova (MNOV) is trading at a price of 1.30, with a previous close of 1.34. The stock has fluctuated within a day range of 1.29 to 1.34, while its 52-week range spans from 1.12 to 2.55.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.